Ralf
Study: ALZHEIMER’S DISEASE – VITAMIN E
“Alzheimer’s and Vitamin E”
Nutrition Week, May 2, 1997;27(17):7/New York Times, April 24, 1997;A22.
Alzheimer’s disease patients were given 2000 IU of vitamin E daily, which is 60 times the RDA, resulting in a significant delay in the progression to 1 of 4 major milestone symptoms: inability to perform basic daily activities, admission to a nursing home, progression to severe dementia or death. Patients taking vitamin E did not experience these events for another 230 days compared to placebo patients.
